A B S T R A C T We have previously shown a marked difference in the inflammatory response to human C5a or C5a des arginine (Arg) instilled in rabbit lungs. These studies raised the question of where C5a and C5a des Arg are processed in vivo and what role neutrophils may play in the tissue distribution of these two mediators. After intravenous injection of purified, biologically active 1251-C5a or 1251-C5a des Arg, adult rabbits were serially bled and then killed at various time intervals. Although >50% of the injected radioactivity was cleared from the circulation within 2 min for both mediators, C5a des Arg persisted in the circulation longer than C5a. C5a instillation caused an acute neutropenia, whereas C5a des Arg caused a less severe and more prolonged neutropenia, preceding a neutrophilic response observed with both mediators. Clearance of the mediators was primarily seen in the highly vascularized organs: the lung, spleen, liver, and kidney. A time-dependent accumulation was seen initially in the lung, followed by the spleen, liver, and kidney. Histologic examination showed a marked increase in the number of neutrophils within the lung and spleen. Depletion of circulating neutrophils by nitrogen mustard pretreatment of rabbits showed no change in the amount of labeled mediator bound in the lung, whereas splenic accumulation was dependent on the presence of neutrophils. These results indicate that C5a and C5a des Arg are rapidly removed from the circulation by specific accumulation in vascularized tissues. Clearance by the lung was not affected by neutrophil depletion, whereas clearance by the spleen was dependent on neutrophils. These experiments further suggest Dr.
INTRODUCTION
Activation of the human complement system by either the classical or alternative pathways results in the generation of the biologically active fragment C5a. The presence of the naturally occurring serum enzyme, carboxypeptidase N, results in the rapid cleavage of the COOH-terminal arginine from C5a forming C5a des arginine (Arg) (1) . Previous reports have shown that although human C5a des Arg shows little, if any, activity as an anaphylatoxin (2) , it has intrinsic properties as an inflammatory mediator (3) (4) (5) . Like C5a, C5a des Arg is capable of stimulating neutrophils to release lysosomal enzymes, to migrate in a directed fashion (chemotaxis), and to generate superoxide anion. Our previous studies showed a differential ability of C5a and C5a des Arg to induce inflammation when instilled in rabbit lungs (6) . These studies raised the question of how C5a and C5a des Arg are processed in vivo. C5a has been suggested to have a systemic effect on numbers of circulating neutrophils. Intravascular instillation of cobra venom factor (to activate the alternative pathway) or C5 fragments has been shown to cause a transient neutropenia followed by neutrophilia (7, 8) . However, the effect of purified C5a or C5a des Arg on circulating neutrophil levels has not yet been reported. It has also been suggested that since C5a and C5a des Arg bind to neutrophils (9) , these inflammatory mediators are distributed in the body as these cells are transported through the vasculature. This current study reports on the kinetics of clearance from the circulation as well as tissue distribution of radiolabeled C5a and C5a des Arg. The effect the C5-J. Clin. Invest (2.5-3 .5 kg) were obtained from L.I.T. Rabbitry, Whitehall, MT, and were maintained on a standard pelleted diet and water. 48 h before injection of labeled C5-fragments, the rabbits were given a potassium iodide-sodium chloride solution (0.03 and 0.1 mg/ml, respectively) instead of water.
Human C5a and C5a des Arg. Human C5a and C5a des Arg were prepared as previously described (5) . The isolated C5-derived peptides were shown to be homogeneous by acid and SDS polyacrylamide gel electrophoresis. Both peptides were radiolabeled with 1251 to 0.8-7.0 qCi/qg sp act using a solid-phase lactoperoxidase-glucose oxidase procedure (Bio-Rad Laboratories, Richmond, CA). The radioactive label was shown to be >95% TCA precipitable. Following the labeling procedure and exhaustive dialysis to remove unbound 1251, some radiolabeled preparations were passed over an affinity column (1 X 3 cm) containing rabbit anti-human C5a coupled to Sepharose-4B. As had been described by Chenoweth and Hugli (4), biologically inactive and antigenically altered C5a passed through the column, whereas biologically active labeled C5a remained bound to the affinity beads. The bound C5a was eluted from the column with 0.1 M glycine, pH 3.0 containing 1.0 M NaCl. Eluted fractions (1.0 ml) containing C5a were pooled and dialyzed vs. water followed by phosphate-buffered (pH 7.2) saline. The column purified '251-C5a or 1251-C5a des Arg was stored at 0°C in wet ice and used within 48 h.
Cobra venom factor. Cobra venom (Bioactive Inc., Arlington, VA) was subjected to DEAE-Sephadex chromatography as described by Cochrane and Muller-Eberhard (10) and treated with p-bromophenacyl bromide to remove any trace phospholipase A2 contamination (11) . The biologic activity of the cobra venom factor (CVF)' was hemolytically assayed and titered (10) . The CVF was used to systeniically generate C5a in vivo by the intravascular instillation of 300 U/animal.
Rabbit heinolytic complement assays. Hemolytic titers of whole rabbit complement (CH50) and rabbit C5 (C5H50) were assayed by a modification of the method of Giclas et al. (12) , as previously described (13) .
Determination of blood volume with serum albumin. Rabbit serum albumin (RSA) was isolated as previously described (13) . It was radiolabeled with "'lI to a specific activity of 3-5 uCi/gg using the lactoperoxidase-glucose oxidase procedure (Bio-Rad Laboratories). To determine tissue blood volume, 3 ytCi of "'I-RSA in 1 ml were injected via a peripheral ear vein 5 min before killing of the rabbit. Samples of tissues were then weighed and placed into plastic couintinig vials and the amount of radioactivity present determined in a gamma counter (Beckman Instruments, Inc., Irvine, CA (14, 15) . These normalized values were used to compare C5a accumulation since they take into account rabbit-to-rabbit variationi in tissue and body weight as well as differences in specific activities of the radiolabeled peptides. The data are expressed as the mean±SEM of R for three rabbits at a given time after injectioni. Due to the variability of urine volume in the bladder at the time of (leatli, these data were calculated as R°= total micrograms of C5a in urine divided by the micrograms of C5a injected per gram of body weight.
Molecular weight determinations. Attempts to estinmate the molecular weight of radiolabeled fragments found in rabbit urine were made by ultrafiltration dialysis and autoradiography of sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis after removal of urinie sedimenit by centrifugation (1,500 g for I5 min). Aliquots of urine (10.0 ml) were placed into low mnolecular weight cutoff (3,500) dialysis tubing (Spectra/Por 3, Spectrum Medical Industries, Inc., Los Angeles, CA) and dialyzed exhaustively vs. phosphate-buffered (pil 7.2) saliine. Ihe amount of radioactivity present in the dialysate and dialysis tubing was determined in a gamma counter and compared to the initial aniounitt of ra(lioactivity. Urine was also electrophoresed on 10-20% linear gradient polyacrylamide gels in the presenice of 0.1% SDS with or without reduction by prior incubation with 2.5% 2-mercaptoethanol (16). Molecular weight markers consisting of cytochrome c (12,400), insulin (5,600), and the a-and f3-chains of reduced insulin (3,300 and 2,300, respectively) were included in each experiment. After staining and drying, the gels were exposed to LKB H film (l,KB Instruments, Rockville, MD) at -70°C for 7-10 d. Exposed film was developed according to the manufacturer's instructions.
RESULTS
Clearance of C5a and C5a des Arg from the circulation. The kinetics of clearance of C5a and C5a des Arg from the circulation of rabbits were determined using radiolabeled peptides. As shown in Fig.  1 , both C5-derived mediators were rapidly cleared from the circulation. Greater than 50% of the radiolabeled fragments were removed within 2 min after injection into the vasculature. By 30 min, <20% of the label was found in the circulation. This amount of radioactivity remained constant up to 4 h (data not shown). It was possible that the intravenous administration of C5a may have caused an alteration of the vascular volume that would affect the rate of clearance of C5a. The absence of change in the rate of clearance of '3'I-RSA given 30 min before the infusion of C5a showed that there was no significant change in vascular volume over 120 min (data not shown). No discernable difference in clearance of either label was observed between whole blood and plasma. Although the differences in clearance between C5a des Arg and C5a were not large, they were very reproducible and statistically significant (P < 0.05, Student's t test) with the clearance of C5a des Arg being less rapid.
This result may explain in part the differences C5a Table I , accumulation of the labeled mediators was primarily seen in the highly vascularized organs of the lung, liver, kidney, and spleen (R = 3.97-20.29). Other examined tissues showed an R value of <0.3. At no time point were significant differences between C5a and C5a des Arg noted in the tissue accumulation of radioactive label. 65.4±3.2% (mean±SEM, n = 34) of the injected material was accounted for by summing the radioactivity recovered in all of the tissues examined. A degree of specificity of accumulation within vascularized tissues was shown by the absence of labeled fragments in the choroid plexus, another very highly vascularized tissue. At early time points, the lung was the most effective site of accumulation of these mediators as shown in Fig. 3 . The R value went from 10.74±1.08 (mean±SEM) at 4 min to 3.30±0.48 by 120 min. Low levels of accumulation by the liver were seen at all time points examined (R = 2.82±0.44 to 1.58±0.18). This was followed sequentially by accumulation in the spleen and kidney. The values for the spleen varied from R = 7.05±3.56 at 4 min to a plateau R value of 19.79±1.33, while the kidney peaked at 30 min (R = 20.29±4.88). Corresponding to a decrease of labeled peptides in the kidney was the accumulation of label in the urine (R* = 82±2 at 4 min; 294±74 at 30 min; and 1,483±275 at 120 min).
The radioactivity found in the urine represented breakdown products of the labeled peptides as only 8.1±1.3% (mean±SEM, n = 8) of the counts were TCA precipitable. After centrifugation of the urine, 15-20% of the total radioactivity was pelleted with the sediment. Further evidence that the radiolabeled peptides had been catabolized into low molecular weight peptides (<3,500), was obtained from ultrafiltration dialysis of the urine as >90% (range 91-95%) of the radiolabel found in the urine passed into the dialysis buffer. Attempts to determine the exact size of the C5a breakdown products in the urine by SDS-polyacrylamide gel electrophoresis were unsuccessful. Incubation of the urine with SDS resulted in the formation 15 R 10. Neutrophil-dependent and independent mechanisms of C5a(C5a des Arg) clearance. Several investigators have shown binding of C5a and C5a des Arg to neutrophils (9, 17) . Histologic examination showed a marked increase in the number of neutrophils within the lung and spleen following the instillation of C5a or C5a des Arg. Therefore, the question arose as to whether the rapid clearance of C5a and C5a des Arg from the circulation was due to binding to neutrophils and subsequent sequestration of the neutrophils in the vascularized tissues. In order to answer this question, normal rabbits or rabbits pretreated with nitrogen mustard to deplete circulating neutrophils, were given radiolabeled C5a or C5a des Arg. The tissues were then examined at various time points for the accumulation of radiolabel. As seen in Fig. 3A , clearance of the labeled mediators through the spleen was markedly dependent on the presence of circulating neutrophils at all examined time points (i.e., neutrophil depletion resulted in a decrease of up to 90% of tissue-bound label). Neutrophil depletion resulted in -30-50% reduction in accumulation of labeled peptides in the liver. Clearance through the kidney (Fig. 3B) , showed a biphasic response to neutrophil depletion; at early time points, it too showedl a neutrophil dependent response for accumulation of the labeled fragments. However, at the later time point (120 min) an increased amount of label was seen in the neutrophildepleted animals.
5-SPLEEN LIVER
Unlike the neutrophil-dependent accumulation of '251-CSa(C5a des Arg) in the liver, spleen, and kidney, a neutrophil-independeint mechanism of accumulation of labeled peptides in the lung was observed at all examined time points (Fig. 3C) . Therefore, neutrophils do not appear to carry C5 fragments to the lung where the radioactivity subsequently accumulates.
The accumulation of radioactivity in the urine at 120 min was also dependent on circulating neutrophils. As shown in Fig. 4 , normal rabbits had 32.2±3.4%
(mean+SENI, n = 3) of the injected label vs. 17.3±2.5% for neuitrophil-depleted animals (P < 0.05). No significant differences between the two groups of animals were seen at the earlier time periods. As had been observed in the urine of normal rabbits, <10% of the radioactivitv was TCA precipitable in the urine of the neutrophil-depleted aiiinials.
C5a(C5a des Arg) accumulation in tissues is a specific process. It wvas conceivable that the data might be explained in part by nonspecific binding of labeled fragments in highly vascularized tissues. Neutrophildepleted rabbits were pretreated 24 FIGURE 4 Effect of neutrophil-depletion of '251-C5a accumulationi in the urine. Experimental conditions were the same as described in Fig. 3 . The data are presented as the percent of injected label (mean±SEM), of three animals in each group. 0, normal rabbits; C, neutrophil-depleted. Neutrophil-depleted ral)hits were given 300 L' (\'F 24 h earlier.
fragments would be expected. As seen in Table II , in vivo generation of chemotactic factors suppressed the binding of '251-C'5a by as much as 64% as compared wvith the non-CVF-treated animals. Thus, specific binding of labeled C5a to the tissues was indicated. A concomitanit increase in radioactivity was seeni in the circulationi of the animals pretreated with C'VF. DISCUSSION lHighly purified, biologically active, radiolabeled C5a and C'5a des Arg were used to study the clearance and tissue distribution of the C5-derived peptides in the rabbit.
Clearanzce of C5a and C5a des Arg from the blood. rhis study has demonstrated that both C5a and C5a des Arg are rapidly removed from the circulation of rabbits. Both molecules showed an initial rapid clearance of <2 min from the circulation. This compares with a previous report of .3 min as measured by aggregometry (18) . The discrepancies in these data may be explained by procedural differences. Despite the initial rapid clearance of both of these mediators, C5a des Arg persisted in the circulation for a longer period of time than C(5a, which may be related to differences in binding affinity between C5a and C5a des Arg as has been shown for neutrophil binding by these molecules (9).
As had been previously shown for CVF (7), human C5-fragments (8) , aind zymosan-activated plasma (8, 19, 20) , instillation of C(5a into the circulation resulted in a rapid, aind near total, neutropenia followed by a neutrophilia. Injection of C5a des Arg, on the other hand, produced a more prolonged neutropeinia than C5a before producing a neutrophilia. These observations are consistent with the fact that C5a des Arg binds less avidly to neutrophils than C5a (9, 17) . Therefore, C5a des Arg remains in the circulation longer and its biological activity may persist longer than C5a. The degree of neutrophilia, seen after both mediators was variable from animal to animal, but was consistently elevated above the initial values. Intravascular instillation of partially purified rabbit CS5a and C5a
In Vivo Clearance and Tissue Distribution of C5a des Arg resulted in similar effects on the levels of circulating neutrophils (21) . However, the absence of purified rabbit C5a precluded its use in these current experiments. The mechanism of action of how these C5-derived peptides cause neutrophilia remains unknown. Because purified molecules were injected into the rabbits, the leukocytosis-inducing activity of C3e (22, 23) would not be likely. Whether C5a and C5a des Arg (or a split-product of these molecules) act similarly to C3e remains a possibility. In any event, the neutrophilia does not appear to be due to endotoxincontamination of the C5-derived peptides. The amount of endotoxin present (<100 ng/ml as detected by a Limulus assay [Associates of Cape Cod, Woods Hole, MA]) was much less than that shown to cause leukocytosis (24, 25) .
Tissue localization of C5a and C5a des Arg. The tissue distribution of C5a and C5a des Arg was primarily confined to the highly vascularized tissues: the lung, liver, spleen, and kidney. Other highly vascularized tissues, such as the choroid plexus, showed no greater accumulation of radiolabeled peptides than skin or muscle. Localization of the labeled peptides within the lung was not dependent on location of the vascular bed through which the mediator first passed. Instillation of C5a into a femoral artery resulted in the same pattern of labeled mediator accumulation as when it was given via the marginal ear vein. This finding contrasts with that recently described for the clearance of thrombin from the circulation in rabbits (26) in which the clearance was markedly dependent on the proximity of the vascular bed to the site of injection.
The specificity of C5a and C5a des Arg binding to vascularized tissues was further shown by in vivo generation of C5a and C5a des Arg by administration of CVF before instillation of labeled C5-peptides. All of the major organs where C5a and C5a des Arg were found to accumulate, now showed a decrease of 40% or greater in the amount of accumulated radioactivity with a concomitant increase in the amount of radioactivity found in the circulation. This suggested that these tissues have specific binding sites for C5-derived peptides.
Role of neutrophils in the tissue distribution of C5a and C5a des Arg. At least two mechanisms appear to be involved in the tissue distribution of C5a and C5a des Arg found within the circulation. Accumulation of radiolabeled peptides in the spleen was markedly neutrophil-dependent. This suggested that C5a and C5a des Arg bind to neutrophils, which are then trapped within the vasculature of the spleen. Such a mechanism is similar to that suggested by Hammerschmidt and co-workers (27) in which neutrophils are thought to be first aggregated by C5a and then become trapped in the microvasculature. However, this mechanism of action does not appear to be true for the lung in which a neutrophil-independent mechanism of C5a and C5a des Arg accumulation was seen.
One cautionary note is that we do not know the possible effect of other leukocytes (e.g., monocytes) in carrying C5 fragments to the lung. Nor do we know for certain the nitrogen mustard treatment results in complete clearance of all marginated neutrophils in the lung by 72 h. However, the neutropenia in the nitrogen mustard-treated rabbits persisted in spite of intravascular instillation of C5a or C5a des Arg (unpublished observation). It appeared likely, however, that C5a and C5a des Arg bind in the pulmonary vascular walls. Circulating neutrophils might then become attached to the endothelium as blood passes through the microvasculature. In vitro experiments by Hoover and co-workers (28) have shown that pretreatment of cultured endothelial cells with C5 fragments or N-formyl-methionine-leucine-phenylalanine will enhance the binding of neutrophils. Our own experiments, however, have so far been unable to reproduce these observations (29) . Attempts to demonstrate direct binding of radiolabeled C5a to the endothelium have been marginally successful at best. Autoradiography of rabbit lung tissue exposed to intravascular '251-C5a has not shown specific accumulation anywhere, apparently because the specific activity of the labeled peptides was not high enough.
Accumulation of radiolabeled peptides in the kidney in neutrophil-depleted animals showed a delayed response compared with neutrophil-sufficient animals. The decreased levels of label at the early time points (4 and 30 min) probably reflected less C5a (C5a des Arg) being processed or carried to the kidney in the absence of circulating neutrophils. On the other hand, the increased clearance of label at the later time point (120 min) could reflect the absence of C5a binding to circulating neutrophils found in normal animals, therefore resulting in more cleared from the blood by the kidney. The appearance of label in the kidney was reflected by the amount of radioactivity found in the urine. It appeared that the presence of neutrophils within the circulation may play a major role in the processing of C5a (C5a des Arg) as has been reported in vitro (30) . In the absence of neutrophils, removal of the labeled peptides still proceeds, but at a slower rate. The radioactivity found in the urine of both groups of animals represented breakdown products of the labeled peptides as determined by TCA precipitation and ultrafiltration dialysis.
Several unresolved questions regarding whether the endothelium plays an active role along with inflammatory cells during inflammation and whether soluble mediators such as complement-derived fragments alter endothelial cell function remain to be investigated. Answers to these questions should give further insight into the basic mechanisms of inflammation within the vasculature.
